Last month, on September 26, 2019, the Centers for Medicare and Medicaid Services (CMS) passed a new rule titled, “Regulatory Provisions to Promote Program Efficiency, Transparency, and Burden Reduction; Fire Safety Requirements for Certain Dialysis Facilities; Hospital and Critical Access Hospital (CAH) Changes to Promote Innovation, Flexibility, and Improvement in Patient Care”. The rule is effectively three rules combined into one, impacting a variety of areas for U.S. healthcare providers that receive reimbursement from Medicare or Medicaid.
The AMR Challenge is a way for organizations around the world to collaborate in the fight against antimicrobial resistance. When the challenge launched, bioMérieux made three commitments to the fight against antimicrobial resistance.
Each year, doctors in the U.S. perform more than 4 billion diagnostic tests, which have become more sophisticated and easier to execute as technology has improved. However, research has found that many physicians assume tests are more accurate than they are.
Lack of resources for action against antimicrobial resistance could have an adverse impact worldwide. In 2017, the World Bank found that by 2050, annual global GDP could fall by up to 3.8% due to the effects of antimicrobial resistance. That 3.8% translates to over 3.4 trillion U.S. dollars in annual economic loss.